A conserved signaling axis linking Drosophila adipose tissue to nephrocyte function reveals how obesity can drive kidney dysfunction and points to new opportunities for therapeutic intervention.

The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...

A 20-year-old Indian doctoral student was shot dead near the University of Toronto Scarborough campus, with authorities ...

Mondego Bio selects PTPN2 inhibitor clinical candidate and targets first-in-human trials in H1 2026: Cantanhede, Portugal Tuesday, December 23, 2025, 17:00 Hrs [IST] Mondego Bio, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

It can be a real pain in the neck. Rheumatoid arthritis, or RA, is an autoimmune disease in which the body mistakenly attacks ...

With this milestone, Mondego Bio is transitioning into clinical-stage operations and plans to initiate a first-in-human (FIH) Phase 1 clinical study in the first half of 2026.

Learn how CBG may support inflammation, gut health, stress, and sleep in 2026, with a science-informed guide to safe, ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is a novel, highly selective inhibitor of the mutated Janus kinase 2 (JAK2) V617F variant ...

Inflammatory molecules circulating in the blood may worsen disease symptoms and points to new opportunities for targeted therapy.